Harmony Biosciences Holdings Inc (HRMY)
31.57
-0.12
(-0.38%)
USD |
NASDAQ |
May 03, 16:00
31.58
+0.01
(+0.03%)
After-Hours: 20:00
Harmony Biosciences Holdings Profit Margin (Quarterly): 24.79% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.79% |
| December 31, 2023 | 15.80% |
| September 30, 2023 | 24.00% |
| June 30, 2023 | 25.56% |
| March 31, 2023 | 24.75% |
| December 31, 2022 | 37.81% |
| September 30, 2022 | 75.03% |
| June 30, 2022 | 21.99% |
| March 31, 2022 | 25.18% |
| Date | Value |
|---|---|
| December 31, 2021 | 24.90% |
| September 30, 2021 | -11.92% |
| June 30, 2021 | 19.12% |
| March 31, 2021 | 12.38% |
| December 31, 2020 | -0.37% |
| September 30, 2020 | 4.19% |
| June 30, 2020 | -0.07% |
| March 31, 2020 | -194.7% |
| December 31, 2019 | -607.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-607.8%
Minimum
Dec 2019
75.03%
Maximum
Sep 2022
-26.63%
Average
20.55%
Median
Profit Margin (Quarterly) Benchmarks
| Amylyx Pharmaceuticals Inc | 4.36% |
| Exelixis Inc | 8.78% |
| Insmed Inc | -222.3% |
| Ultragenyx Pharmaceutical Inc | -96.70% |
| Immunic Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 28.78% |
| Return on Assets | 17.60% |
| Return on Invested Capital | 20.52% |
| Gross Profit Margin (Quarterly) | 82.22% |
| Operating Margin (Quarterly) | 33.65% |
| Return on Net Operating Assets | 60.36% |